Please login to the form below

Not currently logged in
Email:
Password:

priority review

This page shows the latest priority review news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Regeneron receives FDA priority review for prurigo nodularis

Sanofi and Regeneron receives FDA priority review for prurigo nodularis

The US Food and Drug Administration (FDA) has accepted priority review of Sanofi and Regeneron’s jointly developed Dupixent (dupilumab) to treat adults with prurigo nodularis. ... Priority reviews are granted by the FDA for therapies that could

Latest news

More from news
Approximately 6 fully matching, plus 356 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....